Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | PKM | P14618 | 3/20 | 0.68 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24709164 | 0.91 | ALDH1A1 (0.55) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL4403982 | 0.87 | ALDH1A1 (0.51) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL7603742 | 0.87 | ALDH1A1 (0.51) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL4401955 | 0.87 | ALDH1A1 (0.64) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL10015759 | 0.84 | ALDH1A1 (0.48) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL9616111 | 0.84 | ALDH1A1 (0.74) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL712702 | 0.83 | ALDH1A1 (0.68) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL313096 | 0.83 | ALDH1A1 (1.00) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL1232411 | 0.81 | PKM (0.67) | ALDH1A1PKMGAALMNAMAPT | |
| SCHEMBL4401948 | 0.81 | ALDH1A1 (0.54) | ALDH1A1PKMGAALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173756-B2 | Photopolymerizable monomers having epoxide and unsaturated double bonds and their composition | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2012-05-08 | — | — | US | disclosed |
| US-8173756-B2 | Photopolymerizable monomers having epoxide and unsaturated double bonds and their composition | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2012-05-08 | — | — | US | disclosed |
| US-20090163683-A1 | PHOTOPOLYMERIZABLE MONOMERS HAVING EPOXIDE AND UNSATURATED DOUBLE BONDS AND THEIR COMPOSITION | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2009-06-25 | — | — | US | disclosed |
| US-20090163683-A1 | PHOTOPOLYMERIZABLE MONOMERS HAVING EPOXIDE AND UNSATURATED DOUBLE BONDS AND THEIR COMPOSITION | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163683-A1 | PHOTOPOLYMERIZABLE MONOMERS HAVING EPOXIDE AND UNSATURATED DOUBLE BONDS AND THEIR COMPOSITION | PCNA, EPHX2, ALOX12 | ALDH1A1 1077/4885PKM 3228/4885GAA 4414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.